Product and process
Dosage forms, formulations, potency, sensitization, microbial risk, batch sizes, process steps, yields, hold times and cleaning strategy.
Factory development guide · Africa and India
Turn the product and process strategy into premises, critical utilities and equipment that can be operated, cleaned, maintained, qualified and expanded without losing GMP control.
The central rule
A pharmaceutical factory is not a conventional building filled with machines. It is a controlled process environment. Product risks, operating steps, flows, cleaning, data and maintenance must shape the rooms, utilities and equipment.
Current PIC/S PE 009-18 requires premises and equipment to suit their operations, minimize errors, and permit effective cleaning and maintenance. WHO guidance then provides more detailed lifecycle expectations for HVAC, water, validation and—where relevant—sterile manufacture. In India, the revised Schedule M is now the applicable design baseline; the eligible extension period ended on 31 December 2025.
Design input
Each foundation should be written, reviewed and version-controlled. Unresolved assumptions become construction changes later.
Dosage forms, formulations, potency, sensitization, microbial risk, batch sizes, process steps, yields, hold times and cleaning strategy.
National licence, target export markets, procurement expectations, pharmacopoeial commitments, inspection pathway and planned future approvals.
Demand ranges, practical operating days, shifts, campaign lengths, changeovers, planned maintenance, rejects, growth and outsourcing assumptions.
Health-based exposure limits where applicable, dust and aerosol generation, product-contact risks, personnel protection and waste pathways.
Critical quality attributes, critical process parameters, sampling, monitoring, alarms, records, audit trails and release decisions.
Power and water reliability, climate, vendor support, spares, maintainability, expansion, obsolescence and business-continuity requirements.
Integrated planning sequence
Overlap work where it is efficient, but do not bypass the evidence needed to authorize the next capital commitment.
What products, processes, capacities, markets and risks must the site support?
Controlled outputs
Management, Quality, operations, engineering and regulatory teams approve one controlled basis before layouts or purchase specifications are frozen.
Can people, materials, samples, equipment, waste and records move without avoidable mix-up or contamination risk?
Controlled outputs
The concept layout prevents uncontrolled crossing, backtracking and status ambiguity while remaining workable during routine operations.
Which operations may share space or air systems, and which require physical or functional separation?
Controlled outputs
Zoning decisions are justified by product, process and patient risk—not copied from a generic room-classification drawing.
Does every room have a complete, coordinated set of process and engineering requirements?
Controlled outputs
Architectural, mechanical, electrical, process, automation and GMP requirements reconcile to one approved room-level record.
Can each utility meet peak demand, quality, pressure, temperature and recovery needs under realistic conditions?
Controlled outputs
Utilities are sized from process demand and simultaneous-use scenarios, with critical failures and seasonal extremes tested on paper.
Does the URS define what the equipment must achieve and demonstrate—not merely a preferred vendor model?
Controlled outputs
Critical requirements are measurable, testable and traceable through design review, acceptance testing and qualification.
Are design changes, interfaces, installation quality and turnover records controlled as one project?
Controlled outputs
Installed assets match approved requirements and drawings, and discrepancies are resolved before formal qualification is used to discover basic construction defects.
Can evidence demonstrate fitness for intended use and continued control throughout the asset lifecycle?
Controlled outputs
Quality releases each system for use only when evidence, deviations, training, maintenance and operating controls are complete and defensible.
Room data sheets
A controlled room data sheet should connect process, architectural, mechanical, electrical, automation, cleaning and GMP needs before detailed design is approved.
Process steps, materials, maximum occupancy, open or closed product exposure, cleaning method and operating sequence.
Equipment footprint, charging and discharge, doors and hatches, operator movement, service clearances, maintenance removal path and future allowance.
Temperature, relative humidity, pressure relationship, airflow direction, filtration, recovery, dust extraction and monitoring locations.
Floors, walls, ceilings, coving, doors, glazing, penetrations, load capacity, chemical resistance, cleanability and drainage.
Power, earthing, UPS, water grades, steam, gases, vacuum, compressed air, data, lighting, fire detection and emergency utilities.
Access level, interlocks, alarms, BMS or EMS points, local displays, data retention, calibration, logbooks and room-status indication.
Critical utility planning matrix
Utility qualification cannot rescue an unclear design. Define the intended use, required quality, operating range, monitoring and failure response before sizing generation and distribution.
| System | Design objective | Minimum planning evidence | Common trap |
|---|---|---|---|
| HVAC and dust control | Temperature, humidity, pressure, cleanliness, containment and occupant comfort appropriate to process risk. | Air quantity and quality, filtration, air-change and recovery performance, pressure relationships, alarms and seasonal load. | Shared returns spreading dust; inaccessible filters; no source extraction; cooling sized without latent load or future heat gains. |
| Water for pharmaceutical use | The correct water quality for formulation, cleaning, laboratory and other intended uses. | Feed variability, treatment, generation, storage, circulation, sanitization, sampling, online instruments and microbiological control. | Oversized stagnant loops; dead legs; poor drainability; no peak-demand analysis; sampling points that do not represent use. |
| Compressed air and gases | Reliable pressure, flow and quality at the actual point of use, especially where contact with product or critical surfaces occurs. | Oil, water, particles and—where risk requires—microbial quality; dryer, filtration, materials, condensate management and monitoring. | Testing only at the compressor; long wet branches; unidentified use points; no quality specification linked to product risk. |
| Steam and thermal systems | Process heat or clean steam of the defined quality, pressure and capacity for each application. | Boiler treatment, steam quality, traps, condensate, insulation, clean-steam generation, peak loads and safe shutdown. | Using plant steam for an application that needs clean steam; poorly drained lines; simultaneous loads not considered. |
| Electrical power | Safe, stable and sufficient power for production, laboratories, storage and critical environmental control. | Demand and diversity, starting current, harmonics, power quality, earthing, UPS, generator capacity, fuel endurance and load shedding. | A generator sized only by connected kW; critical loads undefined; no restart sequence; sensitive instruments exposed to poor power quality. |
| Vacuum and process gases | Capacity and quality appropriate to the process, with safe distribution and contamination protection. | Worst-case simultaneous demand, receiver size, backflow protection, filtration, leak testing, alarms and cylinder or bulk-gas safety. | Cross-connections; no reserve supply; inadequate ventilation; product ingress into common systems. |
| Drainage and effluent | Hygienic removal, segregation and treatment of liquid waste without backflow or contamination pathways. | Drain necessity, air breaks, traps, slopes, cleanability, process chemistry, hazardous streams, antimicrobial residues and treatment capacity. | Unnecessary drains in clean areas; open channels; reverse flow; incompatible streams combined; effluent obligations considered late. |
| BMS, EMS and monitoring | Timely, reliable evidence that critical facility and utility conditions remain controlled. | Critical parameters, sensor location, alarm limits, delay logic, audit trails, user access, backup, review and calibration. | Every available point treated as critical; nuisance alarms; sensors placed for convenience; data collected but not reviewed. |
Equipment user requirements
The URS should state what must be achieved and verified. A catalogue specification or copied URS usually misses the product, facility, cleaning, data and service interfaces that determine success.
Operating range, accuracy, uniformity, endpoint control, scale-up basis and ability to meet product quality requirements.
Minimum and maximum batch, campaign output, cycle time, changeover, yield, bottleneck impact and credible utilization.
Access, surface finish, seals, joints, drainability, dismantling, cleaning method, residue limits and inspection.
Closed transfer, local extraction, pressure control, dust capture, operator exposure and safe maintenance.
Product-contact construction, elastomers, lubricants, corrosion resistance, certificates and compatibility.
Recipes, access roles, audit trails, electronic records, interfaces, backup, time synchronization and cybersecurity.
Footprint, floor loading, headroom, access, utilities, exhaust, heat rejection, noise and maintenance withdrawal.
Manuals, drawings, software, training, critical spares, local service, warranty, obsolescence and lead times.
Measurable acceptance criteria that can be challenged during design review, FAT, SAT and qualification.
Evidence chain
Requirements, risks, tests, deviations and operating controls should tell one consistent story from the first URS through routine use and retirement.
State intended use, critical requirements, interfaces, data needs and acceptance criteria.
Challenge the proposed design against product, process, patient, operator and data risks.
Compare technical compliance, lifecycle support, delivery risk and total cost—not purchase price alone.
Test critical functions, controls, alarms, documentation and known failure modes before shipment.
Confirm installation condition, interfaces, utilities, safety and functional operation at site.
Establish installation, operating range and performance with traceability to requirements and risks.
Operate through approved procedures, trained personnel, calibration, maintenance, cleaning and monitoring.
Assess modifications, software, relocation and obsolescence; preserve data and controlled decommissioning evidence.
Dosage-form implications
This table is an early planning screen, not a complete design specification. Product-specific science and the competent authority determine the final controls.
| Product family | Typical process chain | Facility, utility and equipment focus |
|---|---|---|
| Non-sterile oral solids | Dispensing, granulation or direct compression, drying, blending, compression or encapsulation, coating and primary packaging. | Dust extraction, humidity where product/process requires it, contained transfer, cleaning access, tooling/change parts and metal detection. |
| Non-sterile liquids | Water preparation, charging, mixing, heating/cooling, bulk holding, transfer, filling, capping and cleaning. | Water-system capacity, microbial control, tank and pipe drainability, protected vents, transfer design, temperature and hold-time control. |
| Creams and ointments | Phase preparation, melting, emulsification, homogenization, vacuum, cooling, bulk holding and filling. | Jacket services, temperature profile, shear, deaeration, vessel geometry, cleanability, transfer losses and controlled bulk hold. |
| Highly sensitizing or potent products | Product-specific manufacture governed by applicable law and a formal cross-contamination and occupational-exposure assessment. | Dedicated or self-contained facilities where required, safe-change areas, contained charging, decontamination, waste and maintenance strategy. |
| Sterile products | Preparation, sterilization, aseptic processing or terminal sterilization, filling, inspection and controlled transfer. | Contamination Control Strategy, cleanroom and barrier design, sterilization, WFI/clean steam, environmental monitoring and Annex 1/WHO sterile GMP expertise. |
| Packaging operations | Primary and secondary packaging, coding, serialization where applicable, inspection, reconciliation and finished-goods transfer. | Line clearance, mix-up prevention, vision and coding controls, temperature-sensitive materials, reject handling and rapid changeover. |
Capacity logic
A practical capacity model connects demand, batch size, complete cycle time, campaigns, bottlenecks, utilities, laboratories, maintenance and working capital.
Start with scheduled operating days and shifts, then deduct sanitation, setup, changeover, planned maintenance, breaks and realistic downtime.
Include staging, charging, processing, in-process testing, discharge, cleaning, drying, line clearance and release dependencies—not machine run time alone.
Balance upstream, downstream, packaging, laboratory and utility capacity. The slowest constrained step defines practical throughput.
Model worst-case batch size, longest cleaning, campaign mix, common equipment, seasonal demand and concurrent utility peaks.
Avoid equipment that meets the maximum forecast but cannot reliably process the smaller launch or low-dose batches.
Reserve defined floor, utility, electrical, automation and material-flow capacity without creating oversized, hard-to-control systems today.
Capital and quality gates
| Gate | Evidence package | Decision rule |
|---|---|---|
| Concept freeze | Design basis, process maps, flows, zoning, room list, utility strategy, capacity model, site risks and expansion concept. | Proceed only when cross-functional reviewers agree that the concept can support the intended products and markets. |
| Basic design freeze | Approved layouts, room data sheets, equipment list, utility balances, control philosophy, EHS basis and preliminary qualification strategy. | Do not authorize major procurement while interfaces, loads or segregation decisions remain undefined. |
| Procurement release | Approved URSs, risk assessment, technical bid comparison, lifecycle support, vendor deliverables, FAT plan and commercial boundaries. | Record deviations from requirements and approve their impact before placing the order. |
| Mechanical completion | Construction checks, installation records, pressure and leak tests, flushing, balancing, calibration, as-builts and punch-list classification. | Separate commissioning defects from qualification; critical open items prevent formal acceptance. |
| Operational release | Qualification reports, approved deviations, maintenance and calibration, SOPs, training, spares, monitoring and change control. | Quality approval is based on complete evidence and controlled residual risk—not the pressure to start production. |
Africa and India implementation
Design for the actual service environment: source-water variability, outages, voltage quality, heat, humidity, dust, long import lead times and limited specialist support may be normal project inputs—not rare emergencies.
The revised Schedule M notified through G.S.R. 922(E) is the current GMP baseline. The time-limited extension route for eligible smaller manufacturers ran to 31 December 2025, so a 2026 project should design to the revised requirements from the outset.
WHO and PIC/S guidance provide a strong technical baseline, but neither replaces the competent authority. Confirm national requirements, product-specific conditions and target-market commitments before design approval.
Avoidable project failures
| Failure pattern | What goes wrong | Better control |
|---|---|---|
| Buying machines before process design | Equipment sizes and utilities are fixed before batch strategy, flows and controls are agreed. | Approve the process and user-requirements basis before technical procurement. |
| Nameplate-capacity optimism | Quoted hourly output ignores setup, hold, cleaning, testing, failures and downstream constraints. | Model complete campaign cycles and test the bottleneck under realistic utilization. |
| Generic room classifications | Rooms are copied from another factory without linking environmental controls to process risk. | Use product and process risk to define zoning, pressure, filtration and monitoring. |
| Utilities sized in isolation | Equipment, HVAC, water and electrical designers use different load assumptions. | Maintain one controlled equipment list, utility matrix and simultaneous-use scenario. |
| No maintenance access | Plant works at handover but filters, motors, valves or large components cannot be safely reached or removed. | Review maintenance tasks and withdrawal routes in 3D before construction. |
| Qualification used as commissioning | IQ/OQ begins while wiring, balancing, controls and basic functions remain incomplete. | Commission and resolve construction defects before formal qualification. |
| Cheap vendor, expensive lifecycle | Limited documentation, proprietary controls, remote service and long spares lead times create chronic downtime. | Evaluate total lifecycle cost, supportability, obsolescence and documentation quality. |
| Resilience added after failure | Backup power, storage, redundancy and contingency procedures are improvised only after interruption. | Use a formal utility-failure assessment during concept design and test recovery before launch. |
Minimum planning package
Project brief; product/process matrix; capacity model; regulatory basis; contamination-control and segregation assessment.
Site and block plans; flow diagrams; zoning; room list; room data sheets; finishes schedule; layouts; area and expansion schedule.
Load list; utility balance; P&IDs; system descriptions; point-of-use specifications; monitoring and alarm matrix; failure assessment.
Equipment list; URSs; technical comparisons; design reviews; FAT/SAT plans; manuals; spares; calibration and maintenance strategy.
Design qualification; quality plan; risk register; change control; commissioning plan; turnover index; qualification strategy and traceability.
SOPs; training; maintenance; calibration; cleaning; monitoring; qualification reports; deviations; release-to-use and lifecycle review plan.
Accessed 20 October 2026. Always confirm current national law, product-specific requirements, licence conditions and target-market commitments before approving a design.
Educational notice: This guide provides general project and GMP education. Facility design, containment, environmental control, engineering calculations, qualification, EHS, licensing and construction require competent specialists and formal approval under applicable law and the manufacturer's pharmaceutical quality system.